HomePortfoliosHigh Growth Portfolio 1

High Growth Portfolio 1

Optimize
None Rebalancing
EUR
Moderate Risk
Multi-currency
2.5yr backtest

Performance Summary

Total Return+67.21%
Annualized Return+22.89%
Volatility+15.77%
Sharpe Ratio1.32
Max Drawdown+24.32%

Holdings

Asset Allocation

Asset Class

Equity 100.0%
Holdings Details
A diversified ETF portfolio with 75% US S&P 500 core, plus targeted allocations to uranium, tech, emerging markets, and healthcare innovation.
AssetTypeAllocationTER
SPYL.XETRA
State Street SPDR S&P 500 UCITS ETF USD Unhedged (Acc)IE000XZSV718
ETF
75.0%0.03%
NUKL.XETRA
VanEck Uranium and Nuclear Technologies UCITS ETF AIE000M7V94E1
ETF
10.0%0.55%
IUIT.LSE
iShares S&P 500 Information Technology Sector UCITS ETF USD (Acc)IE00B3WJKG14
ETF
5.0%0.15%
EMIM.AS
iShares Core MSCI Emerging Markets IMI UCITS ETF (Acc)IE00BKM4GZ66
ETF
5.0%0.18%
HEAL.AS
iShares Healthcare Innovation UCITS ETFIE00BYZK4776
ETF
5.0%0.4%
Total100.0%0.11%

Performance

Portfolio Value Over Time
Starting with 10,000 investment → now worth €16,720.54
Histogram of Monthly Returns
The portfolio had a positive return during 18 of the 30 months (60%)
Monthly Returns Heatmap
Best month: +9.7% • Worst month: -9.1% • Best year: 2024 (+31.5%) • Worst year: 2026 (+5.8%)
YearJanFebMarAprMayJunJulAugSepOctNovDecTotal
2026+2.8%-0.4%-5.7%+9.7%--------+5.8%
2025+3.8%-4.7%-9.1%-4.1%+9.0%+2.9%+6.7%-1.0%+4.9%+6.9%-3.3%-0.6%+10.1%
2024+4.5%+3.8%+3.9%-2.0%+1.3%+6.3%-0.6%-1.1%+2.5%+3.3%+8.1%-1.8%+31.5%
2023----------+5.1%+3.9%+9.2%
> +2%
0% to +2%
-2% to 0%
< -2%
Drawdown Analysis
Maximum drawdown: +24.32% • The longest drawdown period lasted for 7 months and was between January 2025 and September 2025. It reached a trough of -24.3%.

Detailed Metrics

Returns
Total Return
+67.21%
Annualized Return
+22.89%
Avg Monthly Return
+1.83%
Risk
Volatility (Annual)
+15.77%
Max Drawdown
+24.32%
Positive Months
60%
Average Drawdown
-3.9%
Risk-Adjusted
Sharpe Ratio
1.32
Risk-free rate: 2.0%
Sortino Ratio
1.27
Downside risk adjusted
Return/Volatility
1.45
Calmar Ratio
0.94
Return/Max Drawdown
Ulcer Index
5.43
Drawdown depth & duration
Martin Ratio
0.04
Return/Ulcer Index
Backtest Configuration
Initial Investment
10,000
Final Value
16,720.54
Backtest Period
2023-11-01 to 2026-04-30
2.5 years
Rebalancing
none
Base Currency
EUR
High Growth Portfolio 1 | +22.9% CAGR | ETF Backtest